Latest News

All News Media Interview
Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer
NEWS
June 11, 2025

Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer

Read More
Pioneering Precision: How South Korea's Galux is Redefining Antibody Discovery with AI
INTERVIEW
KOREATECHDESK
May 26, 2025

Pioneering Precision: How South Korea's Galux is Redefining Antibody Discovery with AI

Read More
[Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies.
INTERVIEW
KBR
March 20, 2025

[Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies.

Read More
Korean AI firm Galux develops six novel therapeutic antibodies using innovative design methods
INTERVIEW
CHOSUN BIZ
March 20, 2025

Korean AI firm Galux develops six novel therapeutic antibodies using innovative design methods

Read More
Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets
NEWS
March 17, 2025

Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets

Read More
Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design
NEWS
September 19, 2024

Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design

Read More
Galux to conduct joint research with LG Chem on cancer drug development
MEDIA
KOREA JOONGANG DAILY
August 26, 2024

Galux to conduct joint research with LG Chem on cancer drug development

Read More
Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development
NEWS
August 26, 2024

Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development

Read More